How to buy XBiotech stock - 18 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy XBiotech stock

Own XBiotech stock in just a few minutes.

XBiotech Inc is a biotechnology business based in the US. XBiotech shares (XBIT) are listed on the NASDAQ and all prices are listed in US Dollars. XBiotech employs 89 staff and has a trailing 12-month revenue of around USD0.00.

How to buy shares in XBiotech

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for XBiotech. Find the stock by name or ticker symbol: XBIT. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until XBiotech reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of XBiotech, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of XBiotech. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

XBiotech share price

Use our graph to track the performance of XBIT stocks over time.

XBiotech shares at a glance

Information last updated 2021-03-10.
52-week rangeUSD$8.72 - USD$21.48
50-day moving average USD$19.0251
200-day moving average USD$18.6212
Wall St. target priceUSD$18
PE ratio 1.1954
Dividend yield N/A (0%)
Earnings per share (TTM) USD$16.446

Buy XBiotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy XBiotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is XBiotech under- or over-valued?

Valuing XBiotech stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of XBiotech's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

XBiotech's P/E ratio

XBiotech's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, XBiotech shares trade at around 1x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

XBiotech financials

Revenue TTM USD$38.7 million
Gross profit TTM USD$0
Return on assets TTM -7.94%
Return on equity TTM 329.69%
Profit margin 1748.38%
Book value $11.844
Market capitalisation USD$575.3 million

TTM: trailing 12 months

Shorting XBiotech shares

There are currently 1.5 million XBiotech shares held short by investors – that's known as XBiotech's "short interest". This figure is 3.3% down from 1.6 million last month.

There are a few different ways that this level of interest in shorting XBiotech shares can be evaluated.

XBiotech's "short interest ratio" (SIR)

XBiotech's "short interest ratio" (SIR) is the quantity of XBiotech shares currently shorted divided by the average quantity of XBiotech shares traded daily (recently around 121529.61165049). XBiotech's SIR currently stands at 12.36. In other words for every 100,000 XBiotech shares traded daily on the market, roughly 12360 shares are currently held short.

However XBiotech's short interest can also be evaluated against the total number of XBiotech shares, or, against the total number of tradable XBiotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case XBiotech's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 XBiotech shares in existence, roughly 50 shares are currently held short) or 0.1033% of the tradable shares (for every 100,000 tradable XBiotech shares, roughly 103 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against XBiotech.

Find out more about how you can short XBiotech stock.

XBiotech share dividends

We're not expecting XBiotech to pay a dividend over the next 12 months.

XBiotech share price volatility

Over the last 12 months, XBiotech's shares have ranged in value from as little as $8.72 up to $21.48. A popular way to gauge a stock's volatility is its "beta".

XBIT.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XBiotech's is 1.4534. This would suggest that XBiotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

XBiotech overview

XBiotech Inc. , a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. Its product candidates include 514G3, an anti-infective antibody that is in Phase II clinical trial for the treatment of Staphylococcus Aureus infections; and other anti-infectious disease antibodies, which are in pre-clinical development to treat Clostridium Difficile, influenza, Ebola, and Herpes Varicella Zoster (Chickenpox). XBiotech Inc. has a collaboration with BioBridge Global for the development of potential COVID 19 treatment based on natural antibodies from recovered patients. The company was founded in 2005 and is headquartered in Austin, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site